Johnson & Johnson (JNJ) Tops Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Johnson & Johnson (JNJ) PT Lowered to $135 at Stifel
April 17, 2018 5:09 PM EDTStifel lowered its price target on Johnson & Johnson (NYSE: JNJ) to $135.00 (from $145.00) while maintaining a Hold rating following better-than-expected Q1 but some operational puts and takes.
Analyst Rick Wise commented, "Overall, JNJ 1Q18 results were largely as expected with modest top-line outperformance, better-than-expected... More
